
Avella Named One of Inc. 5000's Fastest Growing Companies for Eighth Straight Year
PRESS RELEASE
Avella is #1,772 nationwide with a 3-year growth rate of 234%
August 20, 2014, Phoenix, AZ:
“We are honored to be recognized alongside such an exclusive group of leading companies,” said
Inc. identified companies for this year’s list by measuring growth from 2010 to 2013. Companies must be US-based, privately held, for profit and independent (i.e. not subsidiaries or divisions of other companies) as of Dec. 31, 2013. Avella met the publication’s rigorous criteria for inclusion in the 2014 list based on an average growth rate of 234% percent during this period.
For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, visit
About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In addition to be recognized as one of Inc. Magazine’s 5,000 Fastest Growing Companies for the past eight years, the Arizona Corporate Excellence Awards has also named Avella Specialty Pharmacy as the fastest-growing private company based in the state. For more information, please visit
About Inc.
'Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today’s innovative company builders. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2012 to over 6,000,000 today. For more information, visit
For the latest in Avella news and media resources, please visit
Sincerely,
Todd Speranzo
Vice President, Marketing
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.